ThermoGenesis Holdings, Inc. (THMO)
| Market Cap | 34.66M |
| Revenue (ttm) | 8.06M |
| Net Income (ttm) | -14.16M |
| Shares Out | 11.45M |
| EPS (ttm) | -1.84 |
| PE Ratio | n/a |
| Forward PE | 2.29 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 16 |
| Last Price | $2.75 |
| Previous Close | $2.82 |
| Change ($) | -0.07 |
| Change (%) | -2.48% |
| Day's Open | 2.78 |
| Day's Range | 2.72 - 2.80 |
| Day's Volume | 22,389 |
| 52-Week Range | 1.92 - 7.50 |
Which Reddit penny stocks are investors watching right now? Check these 3 out The post 3 Penny Stocks on Reddit Making Big Waves Right Now appeared first on Penny Stocks to Buy, Picks, News and Informat...
Shares of ThermoGenesis Holdings (NASDAQ:THMO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 85.59% year over year to ($0.16), whi...
RANCHO CORDOVA, Calif., May 13, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...
Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.
RANCHO CORDOVA, Calif., May 6, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today...
RANCHO CORDOVA, Calif., March 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...
RANCHO CORDOVA, Calif., March 10, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, to...
RANCHO CORDOVA, Calif., Feb. 17, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. ("ThermoGenesis" or the "Company") (Nasdaq: THMO), a market leader in automated cell processing tools and services in t...
ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q3 2020 Results - Earnings Call Transcript
RANCHO CORDOVA, Calif., Nov. 12, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, tod...
Health care stocks levered to blood collection and sampling, and plasma therapy biopharma companies are getting a big boost Monday after the FDA issued emergency use authorization for the use of investi...
ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q2 2020 Results - Earnings Call Transcript
RANCHO CORDOVA, Calif., Aug. 14, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc.
RANCHO CORDOVA, Calif., Aug. 11, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings: Many Short-Term Catalysts In Low-Float Stock
RANCHO CORDOVA, Calif., June 23, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, ann...
RANCHO CORDOVA, Calif., June 8, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, anno...
RANCHO CORDOVA, Calif., May 28, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...
ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q1 2020 Results - Earnings Call Transcript
RANCHO CORDOVA, Calif., May 14, 2020 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, toda...
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
As of late, it has definitely been a great time to be an investor in ThermoGenesis Holdings, Inc. (THMO).
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Thermogenesis Holdings Inc (NASDAQ: THMO) shares are trading higher on Thursday.
ThermoGenesis Holdings, Inc. (THMO) CEO Chris Xu on Q4 2019 Results - Earnings Call Transcript
The Reincarnation Of ThermoGenesis With A Better Mousetrap For CAR-T Manufacturing
About THMO
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automa... [Read more...]
| Industry Medical Devices | Founded 1986 |
| CEO Xiaochun Xu | Employees 40 |
| Stock Exchange NASDAQ | Ticker Symbol THMO |
Financial Performance
In 2020, THMO's revenue was $9.74 million, a decrease of -25.32% compared to the previous year's $13.05 million. Losses were -$16.35 million, 72.2% more than in 2019.
Analyst Forecasts
According to one analyst, the rating for THMO stock is "Buy" and the 12-month stock price forecast is 6.00.